Grants for Independent school districts - Health

The purpose of this Notice of Funding Opportunity (NOFO) is to support the establishment of one (1) Center of Excellence (CoE) to coordinate the research community of infectious and immune-mediated disease (IID) computational modelers and advance IID modeling research across biological scales. The CoE must include three (3) coordinating cores and two (2) research projects to advance and integrate bridge models across scales in the context of IID, including HIV/AIDS. The CoE will accelerate multi-scale model development, sharing and re-use, and support collaboration to benefit the entire IID research community.

This funding opportunity supports researchers and organizations in developing new small molecule therapies for mental and neurological disorders, focusing on innovative drug discovery methods without involving clinical trials.

This funding opportunity supports research projects that develop and implement effective strategies to reduce overdose deaths and improve addiction treatment across various settings, targeting diverse populations and addressing health disparities.

This funding opportunity provides financial support for research focused on the long-term health outcomes of youth and young adults in the U.S. living with perinatally acquired HIV, emphasizing the impacts of antiretroviral therapy and associated health challenges.

This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the Scholar can be considered to remain as an investigator within the intramural program.

This funding opportunity provides financial support to a variety of organizations to strengthen public health systems in Cote d'Ivoire, focusing on improving disease detection, response, and prevention capabilities.

The Forever Idaho Regional Grant Program is now accepting applications, with a focus on providing general operating grants to organizations working in areas such as Family Homelessness and Basic Needs, Mental and Physical Health, Educational Opportunities, Access to Services, and Community Benefit. Priority will be given to organizations operating within these areas of impact. If awarded, funds can be used for various direct and indirect costs related to the organization's activities, including payroll, rent, utilities, supplies and equipment, project costs, capital improvements, and programmatic needs. Applicants will be asked to self-select the specific Area of Impact in which they are working.

This grant provides funding for researchers and organizations to develop innovative medical countermeasures for treating acute chemical exposures resulting from terrorist attacks or accidental releases, enhancing national preparedness for chemical emergencies.

This grant provides funding to U.S.-based educational institutions, nonprofits, and community organizations to improve mental health and substance use treatment practices in outpatient settings, particularly for underserved populations.

This grant provides funding for research projects that improve mental health services and outcomes for young people experiencing early stages of psychosis by promoting data-driven care and collaboration among specialized treatment programs across the United States.

This funding opportunity provides financial support for organizations to archive and document child health and human development data sets, facilitating their accessibility for secondary analysis by researchers.

This funding opportunity provides financial support for researchers and organizations developing innovative long-acting treatments for HIV and related co-infections, aiming to improve patient adherence and health outcomes.

This grant provides funding to Oklahoma municipalities, counties, school districts, and public trusts to implement evidence-based strategies for combating the opioid crisis.

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development and validation of reagents/tools to support research to characterize cellular and molecular constituents of the bat immune system and for the study of protective innate and adaptive immune mechanisms in bats. The Research Resource Program established by this NOFO will participate within a collaborative research network to advance understanding of the bat immune response. This NOFO will support the establishment and operation of a Bat Immunology Research Resource Program for the development and validation of reagents/tools for use in immunological studies using the bat model system. The recipient will participate in the Bat Immunology Network, which will consist of the Research Resource Program, the research projects supported by RFA-AI-23-068, and possible other participants as determined by NIAID. The Research Resource Program will conduct reagent/tool development and validation using appropriate systems, which includes testing against multiple bat species. While other members of the Bat Immunology Network may assist in validation efforts, reagent/tool validation is the responsibility of the Research Resource Program. Reagents/tools developed by the Research Resource Program will be provided to the research projects of the Bat Immunology Network. Reagents/tools will be made available to the broader research community through technology transfer arrangements, deposition to nonprofit repositories, and/or timely transfer to industry for commercialization. Areas of high priority include, but are not limited to, the development and validation of the following: Soluble immune molecules (e.g., cytokines, chemokines) for use in tissue culture or in vivo animal studies Antibodies or other probes/detection markers for use in cellular phenotyping, functional studies and/or immunoassays

This funding opportunity supports innovative research aimed at developing new strategies for curing HIV at the start of antiretroviral therapy, targeting researchers and institutions focused on reducing the HIV reservoir and improving immune responses.

The 2024 Choose Henry Fund-Community Grants, offered by the Henry County Community Foundation (HCCF), aim to address the broad needs of Henry County, Indiana. As a community foundation, HCCF's mission is to support diverse areas within the county, including health and medical, social services, education, cultural affairs, and civic affairs. This grant program is aligned with the foundation's overall mission to be responsive to changing community needs, be flexible, and focus on projects with the greatest benefit per dollar granted. The target beneficiaries of these grants are non-profit organizations serving Henry County, specifically those that have been selected through a letter of intent process. The impact goals are to support various programs and facilities that improve the quality of life within the county across the five key areas of interest. This includes, but is not limited to, supporting hospitals and rehabilitation centers, human service organizations, programs for children, youth, and the aged, educational initiatives from pre-school to post-secondary, cultural programs, and civic activities related to criminal justice, community development, and leadership training. The HCCF prioritizes change-oriented and problem-solving initiatives, emphasizing project support rather than ongoing general operating support. The foundation also encourages participation from other contributors through matching challenges and other grant techniques. Additionally, the HCCF aims to coordinate its programs with other funding sources, such as government, other foundations, and associations, to maximize impact. A key focus is to induce grant recipients to achieve objectives like increased efficiency, improved fundraising capabilities, and enhanced product or service delivery. Expected outcomes and measurable results are implicitly tied to the grant evaluation criteria. The foundation assesses whether there is an established need for the requested program or project, its appropriateness for HCCF funding, the adequacy of HCCF resources to respond, and the overall benefit to the community. While specific metrics are not explicitly detailed, the focus on "greatest benefit per dollar granted" and inducing recipients to improve efficiency and service delivery suggests an emphasis on demonstrable positive change and effective resource utilization within Henry County.

This funding opportunity supports research projects that analyze existing national data to improve healthcare access and outcomes for children and adolescents with autism and developmental disabilities, particularly in underserved populations.

This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.The Agency for Healthcare Research and Quality's (AHRQ) mission is to produce evidence to make health care safer, of higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used. This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities. Transition to the R33 phase is not guaranteed for all grants awarded under this FOA. Continuation from the R21 phase to the R33 phase will be determined by AHRQ staff based on progress achieved in the R21 phase and factors such as program priorities and availability of funds.

The National Eye Institute (NEI) supports investigator-initiated, complex, multi-center and other high resource risk epidemiologic studies under the cooperative agreement mechanism, UG1 activity code. Specifically, the purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative ocular epidemiology research.The purpose of this Funding Opportunity Announcement (FOA) is to support epidemiologic studies that utilize creative and innovative approaches to studying vision diseases and disorders with high public impact and whose findings will inform prevention and treatment strategies as well as basic sciences research. Background: Clinical vision research projects, including epidemiologic studies, are part of NEI’s core strategy for improving visual health and decreasing visual impairment in populations through research on the burden of disease, its causes, diagnosis, prevention, treatment and rehabilitation. Projects should focus on NEI’s mission to protect and improve visual health including, but not limited to: Determining the burden of eye diseases and their visual outcomes in a changing population, particularly disparities in the burden and the influences of sociocultural, environmental, economic, and demographic factors. Improving early diagnosis of ocular diseases and their underlying processes through new screening and detection strategies. Determining risk factors for ocular diseases. Identifying and assessing strategies that will overcome barriers to eye care and convert evidence-based findings into improved patient and population outcomes. Studying the interplay of factors that exacerbate or mitigate risk for eye diseases. The NEI encourages applications to support ocular epidemiologic research. These projects are supported under the cooperative agreement mechanism. Applicants are strongly encouraged to contact Scientific/Research staff as plans for an application are being developed (see Section VII, Agency Contacts), preferably no later than 12 weeks prior to the anticipated application submission date.

The "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research" grant aims to fund exploratory research projects that focus on the development of innovative technologies for analyzing molecular or cellular aspects of cancer, with the goal of improving cancer biology research, early detection, diagnosis, treatment, control, epidemiology, and addressing health disparities related to cancer.